Global Dry Eye Medication Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Dry Eye Medication Market Research Report 2024
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
According to Mr Accuracy reports’s new survey, global Dry Eye Medication market is projected to reach US$ 10890 million in 2034, increasing from US$ 8579 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dry Eye Medication market research.
Global Dry Eye Drugs key players include Novartis AG, Valeant Pharmaceuticals, Allergan, Johnson & Johnson, Santen Pharma, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share about 40%, followed by Asia-Pacific, and Europe, both have a share about 40 percent.
In terms of product, Artificial Tears is the largest segment, with a share over 85%. And in terms of application, the largest application is Hospital, followed by Drug Stores, Online Pharmacies.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dry Eye Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
EyeGate Pharmaceuticals
Allergan
Novartis
Merck
Santen Pharmaceutical
Shire
Alcon
Bausch Health Companies
Johnson and Johnson
VISUfarma
Segment by Type
Anti-inflammatory Drugs
Artificial Tears
Punctal Plugs
Secretagogues
Others
Hospital
Pharmacies
Eye Health Clinics
Retail Pharmacies
Online Pharmacies
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Dry Eye Medication report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Dry Eye Medication market is projected to reach US$ 10890 million in 2034, increasing from US$ 8579 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dry Eye Medication market research.
Global Dry Eye Drugs key players include Novartis AG, Valeant Pharmaceuticals, Allergan, Johnson & Johnson, Santen Pharma, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share about 40%, followed by Asia-Pacific, and Europe, both have a share about 40 percent.
In terms of product, Artificial Tears is the largest segment, with a share over 85%. And in terms of application, the largest application is Hospital, followed by Drug Stores, Online Pharmacies.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dry Eye Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
EyeGate Pharmaceuticals
Allergan
Novartis
Merck
Santen Pharmaceutical
Shire
Alcon
Bausch Health Companies
Johnson and Johnson
VISUfarma
Segment by Type
Anti-inflammatory Drugs
Artificial Tears
Punctal Plugs
Secretagogues
Others
Segment by Application
Hospital
Pharmacies
Eye Health Clinics
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Dry Eye Medication report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source